金石亚药：前三季度净利润同比增长66.47%

Core Viewpoint - Jinshiyao Pharmaceutical (300434) reported a decline in revenue for Q3 2025, while showing significant growth in net profit [1] Financial Performance - In Q3 2025, the company achieved revenue of 217 million yuan, a year-on-year decrease of 7.64% [1] - The net profit attributable to shareholders for Q3 2025 was 31.02 million yuan, reflecting a year-on-year increase of 63.90% [1] - For the first three quarters of 2025, the company reported total revenue of 708 million yuan, down 6.37% year-on-year [1] - The net profit attributable to shareholders for the first three quarters was 96.77 million yuan, marking a year-on-year increase of 66.47% [1]